showed a significant benefit in obese patients undergoing BS with BP improvement reported in 63% and resolution in 50% of patients [67] The study by Mingrone et al., the STAMPEDE trial and the Diabetes Surgery Study in DM2 patients undergoing BS vs
Diarrhea on tirzepatide can cause dehydration and electrolyte imbalances that promote water retention
Hibberd MC, Wu M, Rodionov DA, Li X, Cheng J, Griffin NW, Barratt MJ, Giannone RJ, Hettich RL, Osterman AL et al (2017) The effects of micronutrient deficiencies on bacterial species from the human gut microbiota
Targets Two Key Aging Pathways By activating both GLP-1 and GIP pathways, Tirzepatide offers a more comprehensive approach to reversing metabolic aging compared to single-agonist therapies
Additionally, GHK-Cu stimulates the dermal papilla cells, which function as the control center of the hair follicle